Centiva Capital, LP Arrowhead Pharmaceuticals, Inc. Transaction History

Centiva Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$25.16 - $41.38 $146,104 - $240,293	5,807 New	5,807 $207,000
Q4 2021 Feb 14, 2022	SELL	$58.09 - $82.51 $191,697 - $272,283	-3,300 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$58.38 - $84.96 $634,999 - $924,109	-10,877 Reduced 76.72%	3,300 $206,000
Q2 2021 Aug 16, 2021	BUY	$62.15 - $90.32 $881,100 - $1.28 Million	14,177 New	14,177 $1.17 Million

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.23B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.